Prof Farhad Hafezi represented the ELZA Institute at Keracon 2025 in Goa, contributing invited lectures on evidence-based advances in corneal cross-linking and ectasia management.
Prof. Farhad Hafezi presented five-year outcomes and future directions of the sub400 protocol for thin cornea CXL at the KCXL Experts’ Meeting 2025 in Milan.
Emilio Torres-Netto reviewed the evolution of epi-on CXL at KCXL 2025, explaining early failures and how modern protocols now achieve clinically meaningful keratoconus stabilisation.
Prof. Hafezi presented new insights on PACK-CXL, ELZA-PACE, and epi-on CXL at EPOMEC 2025, shaping future keratoconus management.
Ten years after the First Global Consensus, the Second Global Consensus on Keratoconus—reported in EuroTimes—provides an updated, internationally agreed framework for diagnosis, staging, and management. Developed using a modified Delphi process, it reflects a shift from disease stabilisation alone toward individualized care that integrates modern diagnostics, optimized cross-linking strategies, and visual rehabilitation.
ECO-CAIRS, developed at ELZA, uses ultra-high-fluence CXL to optimize donor corneal ring segments for keratoconus surgery. Now published in JRS.
Keratoconus affects not only the cornea but also the retina, choroid, and optic nerve head, as shown in a meta-analysis co-authored by Prof. Farhad Hafezi.
Cataract surgery in keratoconus requires individualized biometry, conservative IOL choice, and careful corneal planning.
ELZA Institute’s Dr. Torres-Netto presents advances in surgical keratoconus treatment and ELZA-PACE-CXL at AAO 2025.
Prof. Hafezi was interviewed by Ocular Surgery News on his co-authorship of the II Global Consensus on Keratoconus – a landmark publication that will guide KC treatment for years to come.
